Stocks · Healthcare · Biotechnology
Keros Therapeutics, Inc. KROS
$11.52 +1.41% Close, Oct 5, 2026 · NASDAQ · Market cap $225.2M
Next earnings report: Nov 4, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Revenue over the last four quarters was $15.0M, down 93.6% from a year earlier, slowing from -84.5% a quarter earlier.
- Diluted EPS over the last four quarters was $-3.22, down 1388.0% year over year.
- Operating margin narrowed to -675.8% from 0.1% a year earlier.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 6, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 5%
- EPS growth (TTM, YoY)Bottom 2%
- FCF growth (TTM, YoY)Bottom 6%
- Revenue growth accelerationBottom 18%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalBottom 37%
- Gross marginTop 14%
- Operating marginBottom 14%
- Accruals (lower is better)Top 28%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldBottom 25%
- Free-cash-flow yieldBottom 23%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 19%
- 6-month returnBottom 39%
- 1-year return vs S&P 500Bottom 25%
- Distance from 52-week highBottom 30%
- Trend checklist (0–4)Top 43%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersBottom 31%
- Consecutive EPS beatsBottom 20%
- Share of analysts rating BuyBottom 24%
- Upside to consensus price targetTop 44%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 35%
- Maximum drawdown, 3 yearsBottom 23%
- Beta vs S&P 500 (lower is better)Bottom 41%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | -84.5% | -93.6% | ↓ |
| Gross margin | 99.6% | 94.7% | ↓ |
| Operating margin | 0.1% | -675.8% | ↓ |
| FCF margin | 22.8% | -322.9% | ↓ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | -93.6% | -84.5% | ↓ | Bottom 5% |
| EPS growth (TTM, YoY) | -1388.0% | — | Bottom 2% | |
| Gross margin | 94.7% | 99.6% | ↓ | Top 14% |
| Operating margin | -675.8% | 0.1% | ↓ | Bottom 14% |
| Net margin | -553.9% | 8.1% | ↓ | — |
| Free-cash-flow margin | -322.9% | 22.8% | ↓ | — |
| Return on invested capital | -35.2% | — | Bottom 37% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -12.2%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 152.3%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- +9.1 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- Net cash
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -0.13%
- Shareholder yield
- -0.13%
- Share count change, 1 year
- -51.2%
- Share count change, 3-year CAGR
- -12.5%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 3, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 0
- Beats in the last 8 reports
- 4 of 8
- Average EPS surprise, last 4
- -7.9%
- Average 2-day reaction, last 8
- -0.4%
- Positive 20 days after report
- 6 of 8
Analysts
- Consensus price target
- $20.33
- Target vs current price
- +76.5%
- Analysts with a rating
- 17
- Share rating Buy or Strong Buy
- 59%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 3, 2026 | -8.2% | +0.4% | +10.7% | +9.5% | — |
| May 14, 2026 | -31.5% | -8.3% | -8.4% | -16.2% | -10.8% |
| Mar 4, 2026 | -75.5% | +2.8% | -13.6% | -17.6% | -15.0% |
| Nov 5, 2025 | +83.8% | +0.6% | +8.7% | +16.4% | +18.3% |
| Aug 6, 2025 | +33.3% | +0.1% | -4.7% | +9.5% | +4.5% |
| May 6, 2025 | +36300.0% | -5.5% | -5.6% | +2.7% | -1.6% |
| Feb 26, 2025 | +16.2% | +0.3% | +6.2% | +3.5% | +28.7% |
| Nov 6, 2024 | -11.9% | +6.2% | +3.7% | +8.3% | -82.4% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 3, 2026 | -$1.45 | -$1.34 | -8.2% | — |
| May 14, 2026 | -$1.21 | -$0.92 | -31.5% | $367,000 |
| Mar 4, 2026 | -$0.86 | -$0.49 | -75.5% | $385,000 |
| Nov 5, 2025 | -$0.18 | -$1.11 | +83.8% | $14.3M |
| Aug 6, 2025 | -$0.76 | -$1.14 | +33.3% | $18.2M |
| May 6, 2025 | $3.62 | -$0.01 | +36300.0% | $211.2M |
| Feb 26, 2025 | -$1.14 | -$1.36 | +16.2% | $3.0M |
| Nov 6, 2024 | -$1.41 | -$1.26 | -11.9% | $388,000 |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| Free-cash-flow yield | -21.53% | — | — | Bottom 23% |
| Earnings yield | -27.95% | — | — | Bottom 25% |
Technical state
Trend checklist
- ✓ Price above 20-day average
- ✓ Price above 50-day average
- ✗ Price above 200-day average
- ✗ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 13
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- +1.5%
- 200-day average slope (20 days)
- -5.7%
- Distance from 50-day average
- +5.1%
- Distance from 200-day average
- -10.5%
- RSI (14)
- 55.1
- Relative volume
- 0.70×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 47.1%
- Volatility vs own 5-year history
- 21th percentile · Normal for this stock
- Beta vs S&P 500 (2 years, weekly)
- 1.28
- Correlation with S&P 500
- 0.25
- Current drawdown from 1-year high
- -47.3%
- Maximum drawdown, 3 years
- -86.5%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Dec 17, 2020 | Apr 1, 2025 | -88.5% | 1075 days | Not yet recovered |
| Oct 28, 2020 | Nov 2, 2020 | -18.1% | 3 days | 10 days (Nov 16, 2020) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $225.2M
- EPS, diluted (TTM)
- -$3.22
- Revenue (TTM)
- $15.0M
- 52-week range
- $9.69 – $22.55
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $20.1M | $0 | $151,000 | $3.5M | $244.1M |
| Gross profit | $20.1M | $0 | $151,000 | $3.5M | $242.6M |
| Operating income | -$56.4M | -$114.8M | -$169.9M | -$210.8M | $70.6M |
| Net income | -$58.7M | -$104.7M | -$153.0M | -$187.4M | $87.0M |
| EPS (diluted) | -$2.52 | -$4.15 | -$5.20 | -$5.00 | $2.30 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $388,000 | $3.0M | $211.2M | $18.2M | $14.3M | $385,000 | $367,000 | $0 |
| Net income | -$53.0M | -$46.0M | $148.5M | -$30.7M | -$7.3M | -$23.5M | -$23.7M | -$28.7M |
| EPS (diluted) | -$1.47 | -$1.14 | $3.62 | -$0.76 | -$0.18 | -$0.38 | -$1.21 | -$1.45 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | -$62.1M | -$70.1M | -$124.5M | -$160.9M | $107.5M |
| Capital expenditure | -$1.0M | -$1.2M | -$2.5M | -$1.9M | -$1.6M |
| Free cash flow | -$63.2M | -$71.3M | -$127.0M | -$162.8M | $106.0M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $28.2M | $119.6M | $175.8M | $380.1M | -$378.5M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $257.6M
- Total assets
- $287.6M
- Total liabilities
- $25.3M
- Total debt
- $15.7M
- Net debt
- -$241.9M
- Shareholders’ equity
- $262.3M
As of Jun 30, 2026 (filed Aug 3, 2026).
Short interest
- Shares sold short
- 1,342,620
- Days to cover
- 9.13
- Change vs previous report
- +15.2%
FINRA short interest, settlement date Sep 15, 2026.